Quality-of-life estimation by Polish and American inflammatory bowel diseases patients – pilot study

Jakubowska-Burek, Ludwika; Warmuz-Stangierska, Izabella; Kaczmarek, Elżbieta; Kucharski, Marcin A.; Marcinkowska, Emilia; Szczepaniak, W.; Mańkowska-Wierzbicka, Dorota; Grzymisławski, Marian; Linke, Krzysztof; Sowiński, Jerzy; Dobrowolska, Agnieszka

doi:10.5114/pg.2011.25995

Cited by 2 publications

(1 citation statement)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…proper dietary management) constitutes one of the most important factors influencing the patient's condition [12][13][14][15][16][17][18][19][20]. Therefore, providing patients with Crohn's disease with proper information and education on maintaining a proper lifestyle that may prevent symptoms of this disease is of such importance [12,13,15,16,[18][19][20][21][22].…”

Section: Introductionmentioning

confidence: 99%

Assessment of the level of knowledge of patients from selected Warsaw hospitals about Crohn’s disease

Turek¹,

Gotlib²

2013

View full text Add to dashboard Cite

Introduction: Crohn's disease constitutes one of the most serious diagnostic-therapeutic problems of contemporary gastroenterology and appropriate lifestyle may prevent symptoms of this disease. Aim of the research: To assess the level of patient knowledge of Crohn's disease. Material and methods:The study enrolled 100 patients from three Warsaw hospitals (53 women). Mean age of the study population was 34.6 years (min. 18, max. 60; SD = 5.690). The voluntary and anonymous questionnaire study used a questionnaire developed by the authors (32 questions). Statistical analysis of the study results was carried out in the StatSoft Statistica 10.0 program, using the Mann-Whitney U test. The significance level was established at p < 0.05. Results: The study group of patients had basic knowledge of Crohn's disease. A majority of the study participants (over 60%) knew the key factors responsible for the development of non-specific inflammatory bowel disease, 64% of them knew the effects of immunosuppressive therapy, and 77% of the patients correctly indicated the group of drugs used in the therapy; however, detailed knowledge of the disease significant for further treatment and its influence on the quality of life was insufficient and required supplementation. Differences among women and men were statistically insignificant (p = NS). Conclusions: Studies on patient knowledge of Crohn's disease are rarely published in Polish and world scientific literature and therefore there is a need for continuation of studies. Detailed knowledge of patients about Crohn's disease was insufficient. Therefore, information campaigns and actions as well as continuous education of patients performed by members of interdisciplinary therapeutic teams are justified. The level of knowledge of Crohn's disease is not gender-related. The study results may be used in practice for development of educational programmes for patients with this disease.

show abstract

Section: Introductionmentioning

confidence: 99%

Assessment of the level of knowledge of patients from selected Warsaw hospitals about Crohn’s disease

Turek¹,

Gotlib²

2013

View full text Add to dashboard Cite

show abstract

Biomarkers in management of inflammatory bowel disease

Moniuszko¹,

Wiśniewska²,

Rydzewska³

2013

View full text Add to dashboard Cite

In recent years the use of faecal and serologic biomarkers has been evaluated in the diagnosis and management of inflammatory bowel disease (IBD). Faecal calprotectin (FC) has been proposed as a surrogate marker for intestinal inflammation; elevated concentrations in IBD patients have been confirmed in numerous studies. Already available rapid calprotectin tests help to differentiate between IBD and irritable bowel syndrome. Faecal calprotectin greatly correlates with endoscopic activity scales and reflects the mucosal healing; thus in patients in clinical remission high levels of it correlate with increased risk of disease relapse in the following 12 months. Adapting the calprotectin assay as a screening test before colonoscopy enables a significant reduction in endoscopic procedures. ANCA/ASCA antibodies have been used in IBD diagnosis and to distinguish CD from ulcerative colitis (UC). Lactoferrin and S100A12 protein were also used to assess the disease activity. This review aims to present the actual potential of biomarker assays for faster diagnosis of IBD and their ability to monitor the disease course, predict exacerbations and improve the way IBD is managed.

show abstract

Quality-of-life estimation by Polish and American inflammatory bowel diseases patients – pilot study

Cited by 2 publications

References 13 publications

Assessment of the level of knowledge of patients from selected Warsaw hospitals about Crohn’s disease

Assessment of the level of knowledge of patients from selected Warsaw hospitals about Crohn’s disease

Biomarkers in management of inflammatory bowel disease

Contact Info

Product

Resources

About